Wen-Hua Liao1, Jin-Wu Chen2, Xin Chen3, Lin Lin1, Hai-Yan Yan4, Yu-Qi Zhou5, Rui Chen6. 1. Department of Respiratory Diseases. 2. Medical Examination Center. 3. Department of Respiratory Diseases, Zhujiang Hospital, Southern Medical University, Guangzhou, China. 4. Department of Clinical Laboratory, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, China. 5. Department of Respiratory Diseases, The Third Affiliated Hospital, Sun Yat-sen University, Guangzhou, China. gzchenrui@163.com zzyyqqcj7605@163.com. 6. Department of Respiratory Diseases gzchenrui@163.com zzyyqqcj7605@163.com.
Abstract
BACKGROUND: The goal of this study was to evaluate the effects of resistance training on subjects with COPD. METHODS: We performed a systematic search in MEDLINE, PubMed, Embase, CINAHL, Elsevier ScienceDirect, EBM Reviews, Cochrane Central Register of Controlled Trials, and ClinicalTrials.gov and also of leading respiratory journals for randomized controlled trials on COPD treatment for ≥ 4 weeks with resistance training compared with non-exercise control or with combined resistance and endurance training compared with endurance training alone. Data from these studies were pooled to calculate odds ratio and weighted mean differences (WMDs) with 95% CI. RESULTS: Eighteen trials with 750 subjects with advanced COPD met the inclusion criteria. There were 2 primary and 5 secondary outcomes. Compared with non-exercise control, resistance training led to significant improvements in the dyspnea domain of the Chronic Respiratory Disease Questionnaire (WMD of 0.59, 95% CI 0.26-0.93, I2 = 0%, P < .001), skeletal muscle strength, and percent-of-predicted FEV1 (WMD of 6.88%, 95% CI 0.41-13.35%, I2 = 0%, P = .04). The combination of resistance and endurance training significantly improved the St George Respiratory Questionnaire total score (WMD of -7.44, 95% CI -12.62 to -2.25, I2 = 0%, P = .005), each domain score, and skeletal muscle strength. There were no significant differences in 6-min walk distance, 6-min pegboard and ring test, maximum exercise work load, and maximum oxygen consumption between the 2 groups. There were no reports of adverse events related to resistance-training intervention. CONCLUSIONS: Resistance training can be successfully performed alone or in conjunction with endurance training without increased adverse events during pulmonary rehabilitation in COPD.
BACKGROUND: The goal of this study was to evaluate the effects of resistance training on subjects with COPD. METHODS: We performed a systematic search in MEDLINE, PubMed, Embase, CINAHL, Elsevier ScienceDirect, EBM Reviews, Cochrane Central Register of Controlled Trials, and ClinicalTrials.gov and also of leading respiratory journals for randomized controlled trials on COPD treatment for ≥ 4 weeks with resistance training compared with non-exercise control or with combined resistance and endurance training compared with endurance training alone. Data from these studies were pooled to calculate odds ratio and weighted mean differences (WMDs) with 95% CI. RESULTS: Eighteen trials with 750 subjects with advanced COPD met the inclusion criteria. There were 2 primary and 5 secondary outcomes. Compared with non-exercise control, resistance training led to significant improvements in the dyspnea domain of the Chronic Respiratory Disease Questionnaire (WMD of 0.59, 95% CI 0.26-0.93, I2 = 0%, P < .001), skeletal muscle strength, and percent-of-predicted FEV1 (WMD of 6.88%, 95% CI 0.41-13.35%, I2 = 0%, P = .04). The combination of resistance and endurance training significantly improved the St George Respiratory Questionnaire total score (WMD of -7.44, 95% CI -12.62 to -2.25, I2 = 0%, P = .005), each domain score, and skeletal muscle strength. There were no significant differences in 6-min walk distance, 6-min pegboard and ring test, maximum exercise work load, and maximum oxygen consumption between the 2 groups. There were no reports of adverse events related to resistance-training intervention. CONCLUSIONS: Resistance training can be successfully performed alone or in conjunction with endurance training without increased adverse events during pulmonary rehabilitation in COPD.
Authors: Fares Gouzi; Jonathan Maury; Nelly Héraud; Nicolas Molinari; Héléna Bertet; Bronia Ayoub; Marine Blaquière; François Bughin; Philippe De Rigal; Magali Poulain; Joël Pincemail; Jean-Paul Cristol; Dalila Laoudj-Chenivesse; Jacques Mercier; Christian Préfaut; Pascal Pomiès; Maurice Hayot Journal: Oxid Med Cell Longev Date: 2019-04-17 Impact factor: 6.543
Authors: Shilpa Dogra; Joshua Good; Matthew P Buman; Paul A Gardiner; Michael K Stickland; Jennifer L Copeland Journal: BMC Public Health Date: 2018-07-03 Impact factor: 3.295
Authors: Sebastian Rutkowski; Joren Buekers; Anna Rutkowska; Błażej Cieślik; Jan Szczegielniak Journal: Sensors (Basel) Date: 2021-04-13 Impact factor: 3.576